Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.86 USD | +1.94% | +2.29% | +37.02% |
10/05 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
09/05 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- MarketScreener Strategies